The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions. PPTA works globally to: • Advocate for access to and affordability of therapies for patients • Engage in constructive dialogue with regulatory agencies • Collaborate with patient advocacy organizations PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients. TERMS OF USE We have set up this page to share information with you and we welcome your comments. We observe LinkedIn’s posting guidelines and terms of use and would ask that you observe them too, in addition to the following terms when commenting on this page. We have a responsibility to manage this page appropriately in line with the regulatory environment in which we operate. Unfortunately, as a result we may have to remove postings, graphics, comments, video, photos or any other content that: - Are potentially libelous, defamatory or disparaging - Violate another’s copyright or intellectual property - Condone or promote illegal activity - Are misleading, fraudulent or deceptive - Uses language that is vulgar, discriminatory or harassing - Are spam or intended to cause technical disruptions to this page - Mention prescription medicines or their side effects - Disclose personal information about a person or their health status - Disclose adverse events to medicines - Offer unauthorized medical advice - Is not related to the post under which it appears While we prefer not to, we reserve the right to ban anyone repeatedly posting material that falls into the above categories from participating in this page. PARTICIPATING IN THIS PAGE PPTA is not responsible for the accuracy of the opinions, information, advice or comments on this page not specifically posted by us. We do not allow sales pitches for products or services to be disguised as comments. INFORMATION ABOUT MEDICINES AND MEDICAL TREATMENT As a pharmaceutical association, we are unable to comment on or advise individual patients about their medical condition and treatment. It is very important that patients are advised by a health professional who knows a patient’s medical and treatment history. SUSPECTED ADVERSE EVENTS Patient and donor safety is of the utmost importance to PPTA and we take all information related to plasma donation and plasma protein therapeutics seriously. We have a legal and ethical duty to disclose any reports of adverse events associated with our members’ medicines to the related manufacturer, which in turn assists us with the administration of our safety standards programs. If you believe you have experienced an adverse event when using one of our members’ products, please contact the manufacturer for more information. If you have any questions about the terms of use of our page, please contact us at http://pptaglobal.org/about-us/contact-us/submit-your-question